CARDIOVASCULAR CONTINUUM INVESTIGATED AT THE MALE WITH CHRONIC GLOMERULONEPHRITIS
Abstract
To address the renal dysfunction characteristics at male with chronic glomerulonephritis in the terms of Cardiovascular and renal continuum. Materials and methods: There are 73 male with proven case o f chronic glomerulonephritis in age from 22 to 60 years old, average rate 35,9±11,1 years were examination in the framework o f that study. Wherefroin at 34 patients, the CDV, CHD, rhythm disturbance. LVH, chronic heart failure were handed and at 39 patients were not handed. Clinical examination was including itself anamnesis, biochemical and routine methods of study. The age o f patients, assumed cholesterol rate, cholesterol I IDL. LDL. triglycerides, concentration o f fibrinogen, TP, creatinine in serum, the presence of concomitant diseases were estimated too. Patients were examining with BP, ECG, US-Heart also. Results: Chronic glomerulonephritis in male has a conjugated bond with earlier development of CVD (average age 35,4±10,8 years). Presence of CVD in male on underdialysis stage o f chronic glomerulonephritis was associated with calcium higher level, accomplishing of anemia with lowerHb concentration and higher level of creatinine concentration in serum (131(91-193) vs. 88 (76-118) p=0,021), difference with male with chronic glomerulonephritis without CVD. Conclusion: Main factors, contribute development of CVD at the patients on underdialysis stage o f chronic glomerulonephritis are: conjugating o f anemia, hypocalcaemia and decrease of GFR that was accompanied with increase of creatinine in serum.
Keywords:
chronic glomerulonephritis, cardiovascular disease (CVD), anemia, glomerular filtration rate (GFR)References
1. Данияров С.Б., Зарифьян А.Г. Работа сердца. Фрунзе. 1978;
2. Миррахимов М. М. Сердечно-сосудистая система в условиях высокогорья. Л., 1968.
3. 0 ’Riordan Е„ Foley R.N. Effects o f anemia on cardiovascular status // Nephrol Dial Transplant. 2000; 15 [suppl 3] : 19-22.
4. Dzau V.J., Antman E.M., Black H.R. et al. The cardiovascular disease continuum validated: clinical evidence o f improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease) // Circulation. 2006; 114: 2850-2870.
5. Dzau V.J., Antman E.M., Black H.R. et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions // Circulation. 2006; 114: 2871-2891.
6. Kannel W.B. Prevalence and natural history of electrocardiographic left ventricular hypertrophy //A m . J. Med. 1983;75:4-11.
7. Беленков Ю.Н, Мареев В.Ю. Сердечно-сосудистый континуум // Сердечная недостаточность. 2002; 3: 7-11.
8. Dries D.L., Exner D.V., Domanski M.J. et al. The prognostic implications ofrenal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction // J. Am. Coll. Cardiol. 2000; 35: 681-689.
9. Magri P., Rao M A„ Cangianiello S. et al. Early impairment o f renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism // Circulation. 1998; 98: 2849-2854.
10. Volpe М., Magri P., Rao M.A. et al. Intrarenal determinants o f sodium retention in mild heart failure: effects o f angiotensin-converting enzyme inhibition // Hypertension. 1997; 30: 168- 176.
11. Locatelli F., Marcelli D., Conte F. et al. Cardiovascular disease in chronic renal failure: the challenge continues. Registro Lombardo Dialisi e Trapianto // Nephrol Dial Transplant. 2000; 15 Suppl 5: 69-80.
12. Гендлин Г.Е., Шило В.Ю., Томилина H.A. и др. Гипертрофия миокарда левого желудочка и ее прогностическое значение у больных с хронической болезни почек. Клиническая нефрология. 2009; 1: 22-28.
13. Casale P.N., Devereux R.B., Milner М. et al. Value o f echocardiographic measurement of left ventriculsr mass in predicting cardiovascular morbid events in hypertensive men // Ann. Intern. Med. 1986; 105: 173-178.
14. Диагностика и лечение артериальной гипертензии. ВНОК. Национальные клинические рекомендации. Москва. 2010.
15. Levey A.S.Controlling the epidemic o f cardiovascular disease in chronic renal disease: Wher do we start? // Am. J. Kidney Dis. 1998; 32:(5),(suppl.3): S5-13.
16. Мухин H.A. Снижение скорости клубочковой фильтрации общепопуляционный маркер неблагоприятного прогноза // Терапевтический архив. 2007; 6: 5-10.
17. Amann К., W olf F., Nicholas С. et al. Aortic changes in experimental renal failure: Hyperplasia or hypertrophy o f smooth muscle cells? //H ypertension. 1997.
18. Ромашова Е.П., Давыдкин И Л . Особенности ремоделирования левого желудочка у больных хронической почечной недостаточностью, получающих лечение амбулаторным гемодиализом // Терапевтический архив. 2009; 1:21-24.
19. Ма J.Z., Ebben J., Xia Н., et al. Hematocrit level and associated mortality in hemodialysis patients. J. Am. Soc Nephrol. 1999; 10: 610-619.
20. Kunitoshi Iseki., Yoshiharu Ikemiya., Chiho Iseki. et al. Haematocrit and the risk of developing end-stage renal disease // Nephrol Dial Transplant. 2003; 18: 899-905.
21 .Levin A., Thompson C. R., Ethier J. et al. Left ventricular mass index in early renal disease: impact o f decline in hemoglobin // Am. J. Kidney Dis. 1999; 34: 125-134.
22. Pyamali, A., Becker, Т., Simmons, W. P. et al. Increasing hematocrit reduces early post transplant cardiovascular risk in diabetic transplant recipients // Transplantation, 2003; 76: (5): 816-820.
23. Anker S.D., Sharma R., The syndrome of cardiac cahexia // Int. J. Cardiol. 2002; 85: 51 -66
24. Chen C.H., Ting C.T., Lin S.J. et al. Which arterial and cardiac parameters best predict left ventricular mass? // Circulation. 1998; Vol. 98: P. 422-428.
25. McMurray J.V., Stewart S. The burden of heart failure. Eur Heart J Suppl 2003; 5: 13-113.
26. Levy D., Anderson K.M., Savage D.D. et al. Prognostic implications o f echocardiographically determined left ventricular mass in the FraminghamHeart Study // N. Engl. J. Med. 1990; Vol. 322:P. 1561.
27. Kannel W.B. Prevalence and natural history of electrocardiographic left ventricular hypertrophy //Am. J. Med. 1983; 75: 4-11.
28. Авдеева M.B., Щеглова Jl.В. Функциональные возможности центров здоровья в выявлении лиц с почечной патологией и риском развития сердечно-сосудистых заболеваний // Клиническая нефрология.2011; №3: С.57-60.
